Skip to main content

Biodexa Pharmaceuticals Plc

BDRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001643918

No open-market purchases or sales by Biodexa Pharmaceuticals Plc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $48.1K in total; no superinvestor holds it.

Superinvestors holding BDRX, Q2 2026

See all superinvestors

No superinvestor reported holding BDRX in Q2 2026.